Page 6 - Rua Bioscience News Today

New Zealand medicinal cannabis company Rua BioScience is on track to selling its high-value pain relief product into Germany.

New Zealand shares fell nearly 1.5% on Monday and were on track for their biggest drop in two years, after hot U.S. inflation data raised worries that the Federal Reserve might stay hawkish for a long... | June 12, 2022

Business Scoop provides news and views on Business and Markets from New Zealand

Scoop Community provides New Zealand Community news and views

NZ's Rua Bioscience's first cannabis medicine, RUA CBD100, is now available on prescription in New Zealand.

Produced at purpose-built Gisborne facility and distributed by CDC Pharmaceuticals.

East Coast-based medicinal cannabis firm Rua Bioscience says it has plenty of other products in the works, after launching its first medicine in New Zealand.

Business Scoop provides news and views on Business and Markets from New Zealand

Best of 2021: Whether it's 'cowgorithms', posts made from recycled plastics or reimagining the wool sector, we spoke to some clever Kiwis this year.

Rua Bioscience has received the go-ahead from New Zealand's government to distribute its first cannabis medicine locally.